1. BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab. Issue 6 (24th March 2017) Authors: Huet, Sarah; Szafer‐Glusman, Edith; Tesson, Bruno; Xerri, Luc; Fairbrother, Wayne J.; Mukhyala, Kiran; Bolen, Chris; Punnoose, Elizabeth; Tonon, Laurie; Chassagne‐Clément, Catherine; Feugier, Pierre; Viari, Alain; Jardin, Fabrice; Salles, Gilles; Sujobert, Pierre Journal: American journal of hematology Issue: Volume 92:Issue 6(2017:Jun.) Page Start: 515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗